BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 6630599)

  • 1. Effectiveness of curettage and electrodesiccation in the removal of basal cell carcinoma.
    Edens BL; Bartlow GA; Haghighi P; Astarita RW; Davidson TM
    J Am Acad Dermatol; 1983 Sep; 9(3):383-8. PubMed ID: 6630599
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Failure of curettage and electrodesiccation for removal of basal cell carcinoma.
    Suhge d'Aubermont PC; Bennett RG
    Arch Dermatol; 1984 Nov; 120(11):1456-60. PubMed ID: 6497413
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biopsy followed by immediate curettage and electrodesiccation of suspected basal cell carcinomas at the first visit.
    White GM; Zhou HC; Burchette RJ
    JAMA Dermatol; 2013 Aug; 149(8):980-1. PubMed ID: 23760141
    [No Abstract]   [Full Text] [Related]  

  • 4. Curettage-electrodesiccation treatment of basal cell carcinomas.
    Kopf AW; Bart RS; Schrager D; Lazar M; Popkin GL
    Arch Dermatol; 1977 Apr; 113(4):439-43. PubMed ID: 848972
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A retrospective study on the effectiveness of curettage and electrodesiccation for clinically suspected primary nodular basal cell carcinoma.
    Lubeek SF; Arnold WP
    Br J Dermatol; 2016 Nov; 175(5):1097-1098. PubMed ID: 27229620
    [No Abstract]   [Full Text] [Related]  

  • 6. Multifocal recurrent basal cell carcinoma following primary tumor treatment by electrodesiccation and curettage.
    Wagner RF; Cottel WI
    J Am Acad Dermatol; 1987 Dec; 17(6):1047-9. PubMed ID: 3429717
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The appropriateness of curettage and electrodesiccation for the treatment of basal cell carcinomas.
    Alexiades-Armenakas M; Ramsay D; Kopf AW
    Arch Dermatol; 2000 Jun; 136(6):800. PubMed ID: 10871955
    [No Abstract]   [Full Text] [Related]  

  • 8. Prospective Clinical Trial Comparing Curettage and Cryosurgery to Curettage and Electrodesiccation in the Management of Minimally Invasive Basal and Squamous Cell Carcinomas [Formula: see text].
    Fournier S; Laroche A; Leblanc M; Bourgeault E; Ulrich Singbo MN; Turcotte S; Blouin MM; Alain J
    J Cutan Med Surg; 2020; 24(6):596-600. PubMed ID: 32721237
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recurrence rates of treated basal cell carcinomas. Part 2: Curettage-electrodesiccation.
    Silverman MK; Kopf AW; Grin CM; Bart RS; Levenstein MJ
    J Dermatol Surg Oncol; 1991 Sep; 17(9):720-6. PubMed ID: 1820764
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of basal cell epithelioma by curettage and electrodesiccation.
    Spiller WF; Spiller RF
    J Am Acad Dermatol; 1984 Nov; 11(5 Pt 1):808-14. PubMed ID: 6512037
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recurrence rates of aggressive histologic types of basal cell carcinoma after treatment with electrodesiccation and curettage alone.
    Blixt E; Nelsen D; Stratman E
    Dermatol Surg; 2013 May; 39(5):719-25. PubMed ID: 23379543
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The treatment of skin cancer by electrodesiccation and curettage.
    Jackson R
    J Surg Oncol; 1983 Feb; 22(2):100. PubMed ID: 6823121
    [No Abstract]   [Full Text] [Related]  

  • 13. Use of curettage and shave excision in office practice. Microscopic confirmation of removal.
    Cott RE; Wood MG; Johnson BL
    J Am Acad Dermatol; 1987 Jun; 16(6):1243-51. PubMed ID: 3597863
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Does inflammation contribute to the eradication of basal cell carcinoma following curettage and electrodesiccation?
    Spencer JM; Tannenbaum A; Sloan L; Amonette RA
    Dermatol Surg; 1997 Aug; 23(8):625-30; discussion 630-1. PubMed ID: 9256908
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SKIN CANCER; TREATMENT BY CURETTAGE AND DESICCATION.
    TROMOVITCH TA
    Calif Med; 1965 Aug; 103(2):107-8. PubMed ID: 14347972
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multivariate risk score for recurrence of cutaneous basal cell carcinomas.
    Dubin N; Kopf AW
    Arch Dermatol; 1983 May; 119(5):373-7. PubMed ID: 6847215
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prospective trial of curettage and cryosurgery in the management of non-facial, superficial, and minimally invasive basal and squamous cell carcinoma.
    Peikert JM
    Int J Dermatol; 2011 Sep; 50(9):1135-8. PubMed ID: 22126880
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Practice gaps. Immediate curettage and electrodessication following biopsy of suspected basal cell carcinoma at initial visit.
    Zwald F
    JAMA Dermatol; 2013 Aug; 149(8):981. PubMed ID: 23760606
    [No Abstract]   [Full Text] [Related]  

  • 19. THE TREATMENT OF SKIN CANCER. A STATISTICAL STUDY OF 1,341 SKIN TUMORS COMPARING RESULTS OBTAINED WITH IRRADIATION, SURGERY, AND CURETTAGE FOLLOWED BY ELECTRODESICCATION.
    FREEMAN RG; KNOX JM; HEATON CL
    Cancer; 1964 Apr; 17():535-8. PubMed ID: 14136537
    [No Abstract]   [Full Text] [Related]  

  • 20. Metastasis in an electrodesiccation and curettage scar.
    Dunn PT; Bigler CF
    J Am Acad Dermatol; 1997 Jan; 36(1):117-8. PubMed ID: 8996278
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.